MapLight Therapeutics, Inc 10-Q for FY2025 Q3
MapLight Therapeutics, Inc. (MPLT)
10-Q
2025-12-04
For: 2025-09-30
View Original
Added on
April 12, 2026
About this 10-Q
MapLight Therapeutics, Inc filed this 10-Q on December 4, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).
Headline figures
Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $29.42M
- compared with a net loss of $19.02M a year earlier
- Diluted EPS
- -$37.18
- compared with -$25.08 a year earlier